MedTrace Logo

Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy Outcomes

NCT06180447 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150000

Last updated 2024-05-07

No results posted yet for this study

Summary

Uing data from a population based cohort in China, we will conduct retrospective cohort study to evaluate the risk of vaccine (e.g., HPV/influenza/rabies vaccine) administered during pregnancy (especially during first trimester) for adverse pregnancy outcomes (e.g., birth defects, preterm birth and low birth weight)

Conditions

  • Vaccine Adverse Reaction

Interventions

BIOLOGICAL

Hepatitis B vaccine, rabies vaccine, HPV vaccine, influenza vaccine

Exposure was defined as use of the vaccine 90 days before the last menstrual period and during pregnancy.

Sponsors & Collaborators

  • Sun Xin

    lead OTHER

Principal Investigators

  • Xin Sun, PhD · Chinese Evidence-based Medicine Center, West China Hospital of Sichuan University

Eligibility

Min Age
14 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-31
Completion
2025-03-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06180447 on ClinicalTrials.gov